Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Amisulpride for Prevention of PONV in Pediatric Patients
NCT05546359Phase 3Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of amisulpride in postoperative nausea and vomiting (PONV), sponsored by Acacia Pharma Group Plc. Started Jan 2024; status: completed.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05546359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05546359.